ES2715102T3 - Método y dispositivo para diagnosticar el potencial de desarrollar una enfermedad cardiovascular - Google Patents
Método y dispositivo para diagnosticar el potencial de desarrollar una enfermedad cardiovascular Download PDFInfo
- Publication number
- ES2715102T3 ES2715102T3 ES14773332T ES14773332T ES2715102T3 ES 2715102 T3 ES2715102 T3 ES 2715102T3 ES 14773332 T ES14773332 T ES 14773332T ES 14773332 T ES14773332 T ES 14773332T ES 2715102 T3 ES2715102 T3 ES 2715102T3
- Authority
- ES
- Spain
- Prior art keywords
- cvd
- data
- vascular
- fmdmax
- total
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000024172 Cardiovascular disease Diseases 0.000 title claims abstract description 185
- 238000000034 method Methods 0.000 title claims abstract description 48
- 230000002792 vascular Effects 0.000 claims abstract description 115
- 230000001404 mediated effect Effects 0.000 claims abstract description 19
- 238000004891 communication Methods 0.000 claims description 19
- 210000001367 artery Anatomy 0.000 claims description 18
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 16
- 238000004458 analytical method Methods 0.000 claims description 13
- 230000010339 dilation Effects 0.000 claims description 13
- 210000002302 brachial artery Anatomy 0.000 claims description 12
- 230000000391 smoking effect Effects 0.000 claims description 9
- 230000035488 systolic blood pressure Effects 0.000 claims description 9
- 235000012000 cholesterol Nutrition 0.000 claims description 8
- 206010012601 diabetes mellitus Diseases 0.000 claims description 8
- 238000012285 ultrasound imaging Methods 0.000 claims description 8
- 230000008859 change Effects 0.000 claims description 7
- 238000002604 ultrasonography Methods 0.000 claims description 7
- 239000008280 blood Substances 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 claims description 6
- 230000017531 blood circulation Effects 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 102000001554 Hemoglobins Human genes 0.000 claims description 3
- 108010054147 Hemoglobins Proteins 0.000 claims description 3
- 210000004204 blood vessel Anatomy 0.000 claims description 3
- 210000001715 carotid artery Anatomy 0.000 claims description 3
- 238000005206 flow analysis Methods 0.000 claims description 3
- 150000002632 lipids Chemical class 0.000 claims description 3
- 230000000241 respiratory effect Effects 0.000 claims description 3
- 230000000284 resting effect Effects 0.000 claims description 3
- 230000001939 inductive effect Effects 0.000 claims description 2
- 239000000117 blood based biomarker Substances 0.000 claims 2
- 230000036770 blood supply Effects 0.000 claims 1
- 230000000004 hemodynamic effect Effects 0.000 claims 1
- 206010020565 Hyperaemia Diseases 0.000 description 11
- 230000000638 stimulation Effects 0.000 description 10
- 238000013500 data storage Methods 0.000 description 9
- 238000005259 measurement Methods 0.000 description 9
- 238000010586 diagram Methods 0.000 description 6
- 230000002526 effect on cardiovascular system Effects 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 230000002093 peripheral effect Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 230000024883 vasodilation Effects 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 5
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
- 208000022061 active hyperemia Diseases 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 208000022064 reactive hyperemia Diseases 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 230000035882 stress Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 3
- 230000007211 cardiovascular event Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 206010048554 Endothelial dysfunction Diseases 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 230000008694 endothelial dysfunction Effects 0.000 description 2
- 210000003038 endothelium Anatomy 0.000 description 2
- 238000013213 extrapolation Methods 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000010197 meta-analysis Methods 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 238000013186 photoplethysmography Methods 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010053648 Vascular occlusion Diseases 0.000 description 1
- 206010047141 Vasodilatation Diseases 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036996 cardiovascular health Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 230000008753 endothelial function Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000012502 risk assessment Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 208000021331 vascular occlusion disease Diseases 0.000 description 1
- 238000009553 vascular ultrasonography Methods 0.000 description 1
- 239000002550 vasoactive agent Substances 0.000 description 1
- 230000002227 vasoactive effect Effects 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/02007—Evaluating blood vessel condition, e.g. elasticity, compliance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
- A61B5/02055—Simultaneously evaluating both cardiovascular condition and temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/02108—Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/02108—Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics
- A61B5/02116—Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics of pulse wave amplitude
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
- A61B5/0295—Measuring blood flow using plethysmography, i.e. measuring the variations in the volume of a body part as modified by the circulation of blood therethrough, e.g. impedance plethysmography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4806—Sleep evaluation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6887—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient mounted on external non-worn devices, e.g. non-medical devices
- A61B5/6898—Portable consumer electronic devices, e.g. music players, telephones, tablet computers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7278—Artificial waveform generation or derivation, e.g. synthesizing signals from measured signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7282—Event detection, e.g. detecting unique waveforms indicative of a medical condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/04—Constructional details of apparatus
- A61B2560/0475—Special features of memory means, e.g. removable memory cards
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
- A61B5/0261—Measuring blood flow using optical means, e.g. infrared light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/06—Measuring blood flow
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Surgery (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Artificial Intelligence (AREA)
- Psychiatry (AREA)
- Signal Processing (AREA)
- Hematology (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Pulmonology (AREA)
- Multimedia (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Computer Networks & Wireless Communication (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361778424P | 2013-03-13 | 2013-03-13 | |
| PCT/US2014/026895 WO2014160515A1 (en) | 2013-03-13 | 2014-03-13 | Flow-mediated dilation to determine vascular age |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2715102T3 true ES2715102T3 (es) | 2019-05-31 |
Family
ID=51625446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES14773332T Active ES2715102T3 (es) | 2013-03-13 | 2014-03-13 | Método y dispositivo para diagnosticar el potencial de desarrollar una enfermedad cardiovascular |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10568582B2 (enExample) |
| EP (1) | EP2967362B1 (enExample) |
| JP (1) | JP6549094B2 (enExample) |
| KR (1) | KR20150137060A (enExample) |
| CN (1) | CN105283120B (enExample) |
| AU (1) | AU2014243720B2 (enExample) |
| BR (1) | BR112015023253A2 (enExample) |
| CA (1) | CA2904631A1 (enExample) |
| ES (1) | ES2715102T3 (enExample) |
| IL (1) | IL240932B (enExample) |
| MX (1) | MX2015012585A (enExample) |
| RU (1) | RU2015143711A (enExample) |
| SG (1) | SG11201506960XA (enExample) |
| TR (1) | TR201903691T4 (enExample) |
| WO (1) | WO2014160515A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11894116B1 (en) * | 2022-12-01 | 2024-02-06 | Oceandrive Ventures, LLC | Apparatus for extending longevity and a method for its use |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015142808A1 (en) * | 2014-03-17 | 2015-09-24 | Arizona Board Of Regents On Behalf Of Arizona State University | System and method for measuring artery thickness using ultrasound imaging |
| EP3316766A4 (en) * | 2015-07-01 | 2019-01-30 | Everist Genomics, Inc. | SYSTEM AND METHOD FOR ASSESSING THE ENDOTHEL FUNCTION |
| US10043327B2 (en) * | 2016-06-14 | 2018-08-07 | International Business Machines Corporation | Using embedded electromagnetic signatures to monitor and authorize collection of printed material |
| CA3077703A1 (en) | 2017-10-24 | 2019-05-02 | Adventia Technology, LLC | Systems, methods, and devices for aggregated health data processing and treatment recommendation generation platforms |
| CN108185996B (zh) * | 2017-12-27 | 2020-01-10 | 中国科学院深圳先进技术研究院 | 动脉血管年龄估算模型构建方法和装置 |
| EP3853861A4 (en) * | 2018-09-21 | 2022-06-15 | Henry Ford Health System | PROCEDURE FOR DETERMINING VASSY ACCESS RISK IN THE HEMODIALYSIS PATIENT POPULATION |
| CN109171812B (zh) * | 2018-09-26 | 2021-08-10 | 南京邮电大学 | 一种基于弹性模量的颈动脉衰老预测方法 |
| RU2725294C1 (ru) * | 2019-08-23 | 2020-06-30 | Самсунг Электроникс Ко., Лтд. | Персонализированная система формирования рекомендаций пользователю в реализации здорового образа жизни |
| KR20210104410A (ko) * | 2020-02-17 | 2021-08-25 | 삼성전자주식회사 | 생체정보 추정 장치 및 방법과, 초음파 장치 및 모바일 장치 |
| US12640266B2 (en) * | 2020-11-20 | 2026-05-26 | Villanova University | Diagnostic tool for analyzing results of flow mediated dilation |
| US12672845B2 (en) | 2020-12-22 | 2026-07-07 | University Of Washington | System and method for measuring total blood volume with ultrasound |
| CN113229787A (zh) * | 2021-03-22 | 2021-08-10 | 安庆师范大学 | 基于脉搏信号形状特征的血管年龄估算及有效性评价方法 |
| US20220336104A1 (en) * | 2021-04-16 | 2022-10-20 | Withings | Devices, Systems and Processes to Compute A Vascular Health Related Score |
| RU207080U1 (ru) * | 2021-07-13 | 2021-10-11 | Борис Игоревич Левицкий | Измерительный модуль для телемедицинской информационной системы |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002024401A (ja) * | 2000-07-06 | 2002-01-25 | Takeda Chem Ind Ltd | 疾病の治療および予防の指導・支援システム |
| JP5179707B2 (ja) * | 2005-06-17 | 2013-04-10 | フクダ電子株式会社 | 血管弾性指数の経時推移レポート及びその生成方法並びに生体情報出力装置 |
| JP2007065892A (ja) * | 2005-08-30 | 2007-03-15 | Ginga Kobo:Kk | 抗加齢管理システム |
| US8016761B2 (en) * | 2006-10-23 | 2011-09-13 | The General Electric Company | Method and apparatus for automated flow mediated dilation |
| US8409104B2 (en) * | 2008-05-02 | 2013-04-02 | Conopco Inc. | Heart age assessment |
| JP5346555B2 (ja) * | 2008-11-04 | 2013-11-20 | 富士フイルム株式会社 | 動脈硬化リスク表示機能を備えた超音波診断装置 |
| US8057400B2 (en) | 2009-05-12 | 2011-11-15 | Angiologix, Inc. | System and method of measuring changes in arterial volume of a limb segment |
| ES2757847T3 (es) * | 2009-06-02 | 2020-04-30 | Cordex Systems Inc | Método para detectar y evaluar la hiperemia reactiva mediante pletismografía segmentaria |
| US20110270051A1 (en) * | 2010-05-03 | 2011-11-03 | Morteza Naghavi | Cardiovascular Disease Screening Method and Apparatus |
| WO2012116997A1 (en) | 2011-02-28 | 2012-09-07 | Farmicom Pharmaceutical Company D.O.O. | TREATMENT OF ARTERIAL AGEING BY HMG CoA REDUCTASE INHIBITOR |
| WO2012149209A1 (en) * | 2011-04-26 | 2012-11-01 | The Regents Of The University Of California | Assessing endothelial function using a blood pressure cuff |
-
2014
- 2014-03-13 CN CN201480014033.XA patent/CN105283120B/zh not_active Expired - Fee Related
- 2014-03-13 TR TR2019/03691T patent/TR201903691T4/tr unknown
- 2014-03-13 AU AU2014243720A patent/AU2014243720B2/en not_active Ceased
- 2014-03-13 KR KR1020157025551A patent/KR20150137060A/ko not_active Abandoned
- 2014-03-13 MX MX2015012585A patent/MX2015012585A/es unknown
- 2014-03-13 WO PCT/US2014/026895 patent/WO2014160515A1/en not_active Ceased
- 2014-03-13 ES ES14773332T patent/ES2715102T3/es active Active
- 2014-03-13 SG SG11201506960XA patent/SG11201506960XA/en unknown
- 2014-03-13 JP JP2016502272A patent/JP6549094B2/ja not_active Expired - Fee Related
- 2014-03-13 BR BR112015023253A patent/BR112015023253A2/pt not_active IP Right Cessation
- 2014-03-13 CA CA2904631A patent/CA2904631A1/en not_active Abandoned
- 2014-03-13 US US14/774,632 patent/US10568582B2/en not_active Expired - Fee Related
- 2014-03-13 EP EP14773332.3A patent/EP2967362B1/en active Active
- 2014-03-13 RU RU2015143711A patent/RU2015143711A/ru not_active Application Discontinuation
-
2015
- 2015-08-31 IL IL240932A patent/IL240932B/en active IP Right Grant
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11894116B1 (en) * | 2022-12-01 | 2024-02-06 | Oceandrive Ventures, LLC | Apparatus for extending longevity and a method for its use |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2014243720B2 (en) | 2018-10-18 |
| MX2015012585A (es) | 2016-10-13 |
| KR20150137060A (ko) | 2015-12-08 |
| CN105283120B (zh) | 2018-02-09 |
| CA2904631A1 (en) | 2014-10-02 |
| IL240932A0 (en) | 2015-11-30 |
| EP2967362A4 (en) | 2016-10-05 |
| US10568582B2 (en) | 2020-02-25 |
| WO2014160515A1 (en) | 2014-10-02 |
| IL240932B (en) | 2019-06-30 |
| TR201903691T4 (tr) | 2019-05-21 |
| RU2015143711A3 (enExample) | 2018-03-14 |
| CN105283120A (zh) | 2016-01-27 |
| SG11201506960XA (en) | 2015-10-29 |
| EP2967362A1 (en) | 2016-01-20 |
| HK1220336A1 (zh) | 2017-05-05 |
| US20160029972A1 (en) | 2016-02-04 |
| EP2967362B1 (en) | 2018-12-12 |
| JP2016515878A (ja) | 2016-06-02 |
| JP6549094B2 (ja) | 2019-07-24 |
| AU2014243720A1 (en) | 2015-09-24 |
| BR112015023253A2 (pt) | 2017-07-18 |
| RU2015143711A (ru) | 2017-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10568582B2 (en) | System and method for using flow-mediated dilation to provide an adjusted vascular age as an indicator of risk of cardiovascular disease | |
| Lin et al. | New photoplethysmogram indicators for improving cuffless and continuous blood pressure estimation accuracy | |
| Lu et al. | Exploring the best predictors of fluid responsiveness in patients with septic shock | |
| Yao et al. | The value of the inferior vena cava area distensibility index and its diameter ratio for predicting fluid responsiveness in mechanically ventilated patients | |
| ES2757847T3 (es) | Método para detectar y evaluar la hiperemia reactiva mediante pletismografía segmentaria | |
| JP6789280B2 (ja) | 内皮機能を評価するシステムおよび方法 | |
| ES2689660T3 (es) | Método para la determinación no invasiva de una función endotelial y un dispositivo para llevar a cabo dicho método | |
| RU2268639C2 (ru) | Способ пульсометрической оценки функционального состояния и характера вегетативной регуляции сердечно-сосудистой системы человека | |
| JP2016515878A5 (enExample) | ||
| Palombo et al. | Large artery remodeling and dynamics following simulated microgravity by prolonged head‐down tilt bed rest in humans | |
| Stenglova et al. | Continuous non-invasive arterial pressure assessment during surgery to improve outcome | |
| US20240268694A1 (en) | Noninvasive Structural and Valvular Abnormality Detection System based on Flow Aberrations | |
| Gomez et al. | Pulse pressure amplification and arterial stiffness in low-risk, uncomplicated pregnancies | |
| Henschke et al. | Responsiveness of two methods for measuring foot and ankle volume | |
| Kasikcioglu et al. | Aortic distensibility and left ventricular diastolic functions in endurance athletes | |
| Koelwyn et al. | Ultrasonography and tonometry for the assessment of human arterial stiffness | |
| BR112016020760B1 (pt) | Método e dispositivo para a detecção e avaliação de hiperemia reativa usando pletismografia segmentar | |
| Song et al. | Non-invasive hemodynamic diagnosis based on non-linear pulse wave theory applied to four limbs | |
| Trbovich et al. | Impact of tetraplegia vs. paraplegia on venoarteriolar, myogenic and maximal cutaneous vasodilation responses of the microvasculature: Implications for cardiovascular disease | |
| Liu et al. | Application of multiscale entropy in arterial waveform contour analysis in healthy and diabetic subjects | |
| Wiard | Validation of Non-Invasive Standing Arterial Stiffness Measurements Using Ballistocardiography and Photoplethysmography | |
| Schrauf | Monitoring blood pressure: do method and body location matter? | |
| Shlimon | Systemic alterations in vascular morphology and function in men with abdominal aortic aneurysm: With special reference to upper limb arteries and arterial regulation during sympathetic activation | |
| Alhalimi | Measures of arterial stiffness: standardization, various devices, and measurement conditions | |
| MATHIEU et al. | Using the Photoplethysmogram Signal to Assess Cardiovascular Health |